1. Home
  2. NVAX vs PLUG Comparison

NVAX vs PLUG Comparison

Compare NVAX & PLUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • PLUG
  • Stock Information
  • Founded
  • NVAX 1987
  • PLUG 1997
  • Country
  • NVAX United States
  • PLUG United States
  • Employees
  • NVAX N/A
  • PLUG N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • PLUG Industrial Machinery/Components
  • Sector
  • NVAX Health Care
  • PLUG Energy
  • Exchange
  • NVAX Nasdaq
  • PLUG Nasdaq
  • Market Cap
  • NVAX 2.0B
  • PLUG 1.9B
  • IPO Year
  • NVAX 1995
  • PLUG 1999
  • Fundamental
  • Price
  • NVAX $9.76
  • PLUG $2.02
  • Analyst Decision
  • NVAX Buy
  • PLUG Hold
  • Analyst Count
  • NVAX 6
  • PLUG 26
  • Target Price
  • NVAX $17.83
  • PLUG $4.99
  • AVG Volume (30 Days)
  • NVAX 7.2M
  • PLUG 37.8M
  • Earning Date
  • NVAX 11-07-2024
  • PLUG 11-07-2024
  • Dividend Yield
  • NVAX N/A
  • PLUG N/A
  • EPS Growth
  • NVAX N/A
  • PLUG N/A
  • EPS
  • NVAX N/A
  • PLUG N/A
  • Revenue
  • NVAX $987,667,000.00
  • PLUG $684,486,000.00
  • Revenue This Year
  • NVAX N/A
  • PLUG N/A
  • Revenue Next Year
  • NVAX N/A
  • PLUG $46.28
  • P/E Ratio
  • NVAX N/A
  • PLUG N/A
  • Revenue Growth
  • NVAX N/A
  • PLUG N/A
  • 52 Week Low
  • NVAX $3.53
  • PLUG $1.60
  • 52 Week High
  • NVAX $23.86
  • PLUG $6.96
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 36.20
  • PLUG 48.47
  • Support Level
  • NVAX $9.52
  • PLUG $2.05
  • Resistance Level
  • NVAX $10.63
  • PLUG $2.42
  • Average True Range (ATR)
  • NVAX 0.57
  • PLUG 0.13
  • MACD
  • NVAX -0.12
  • PLUG -0.00
  • Stochastic Oscillator
  • NVAX 9.97
  • PLUG 30.21

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

About PLUG Plug Power Inc.

Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.

Share on Social Networks: